Patient Satisfaction With Virtual Post Operative Visits: Hip Arthroscopy

NCT ID: NCT04302077

Last Updated: 2022-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-15

Study Completion Date

2021-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, randomized study designed to evaluate the effects of different initial postoperative follow-up modalities. Given the nature of the study, it is not possible for either the surgeons or the subjects to be blinded. Patients will be assigned to either group based on the last digit of their medical record number (MRN). Patients with an even-ending medical record number will be randomized to virtual visit/telemedicine, while patients with an odd-ending medical record number will be randomized to the office visit.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to evaluate the differences between two forms of postoperative follow-up with respect to patient satisfaction. The primary outcome will be patient satisfaction with their surgeon and with their overall experience. Following their second postoperative visit, the subjects will complete one electronic survey. The survey is designed to assess subject's overall satisfaction and satisfaction with their surgery. This survey is standardized and will be used by both groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Femoroacetabular Impingement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Telemedicine Post Op

Patients with an even-ending medical record number (0,2,4,6,8) will be randomized to virtual visit/telemedicine. This will be done by using Epic and MyChart-integrated telemedicine functionality for video visits with the Principal Investigator's patients. This is considered standard of care.

Group Type ACTIVE_COMPARATOR

virtual doctor visit

Intervention Type OTHER

interactive live-video feed at home through EPIC

In-Office Post Op

Patients with an odd-ending medical record number (1,3,5,7,9) will be randomized to the office visit.

Group Type ACTIVE_COMPARATOR

Standard care doctor's visit

Intervention Type OTHER

In person visit as per standard of care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

virtual doctor visit

interactive live-video feed at home through EPIC

Intervention Type OTHER

Standard care doctor's visit

In person visit as per standard of care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants undergoing arthroscopic hip surgery

Exclusion Criteria

* Age \< 18 years old or Age \> 70 years old
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NYU Langone Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guillem Gonzalez-Lomas

Role: PRINCIPAL_INVESTIGATOR

NYU Langone

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

NYU Langone Health

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

19-01949

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Painful Post-Operative Hip Study
NCT07066709 NOT_YET_RECRUITING PHASE2